[1] Kordon C, Gallard R, Christen Y. (2005). Research and Perspectives in Endocrine Interactions
Hormones and the Brain (pp. 79-98). New York, NY: Springer.
[2] Ashok BT, Chen Y, Liu X, Bradlow HL, Mittelman A, Tiwari RK. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol. Nutr Cancer 2001;41(1-2):180-7.
[3] Ashok BT, Chen YG, Liu X, Garikapaty VP, Seplowitz R, Tschorn J, Roy K, Mittleman A, Tiwari RK. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S86-93.
[4] Broadbent TA, Broadbent HS. The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole. [Part II]. Curr Med Chem 1998 Dec;5(6):469-91.
[5] Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 1994 Jan 19;86(2):126-31.
[6] Edelstam G, Lecander I, Larsson B, Astedt B. Fibrinolysis in the peritoneal fluid during adhesions, endometriosis, and ongoing pelvic inflammatory disease. Inflammation, Vol. 22, No. 4, 1998.
[7] Mazzone A, Catalan M, Costanzo M, Drusian A, Mandol A, Russo S, Guarini E, Vesperini G. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res. 1990 Sep-Oct;18(5):379-88.
[8] Tachibana M, Mizukosi 0, Harada Y, Kawamoto K, Nakai Y. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica, 3(8):526-30 1984.
[9] Mazzone A, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res 1990; 18(5):379-88.
[10] Aso T et al. Breast engorgement and its treatment: Clinical effects of Danzen an anti-inflammatory enzyme preparation. The World of Obstetrics and Gynecology (Japanese). 1981; 33:371-9.
[11] Nakamura S, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology Vol 8 #3, Sept 2003, p.316-320 doi:10.1046/j.1440-1843.2003.00482.
[12] Stange R, Schneider R, Maurer R, and et al. Proteolytic enzyme bromelain enhances cytotoxicity in patients with breast cancer [abstract]. National Scientific Conference on Complementary, Alternative & Integrative Medicine Research, April 12 - 14 2002.
[13] Kleine MW. Introduction to oral enzyme therapy. Int J Immunotherapy 1997;13(3-4):59-65.
[14] Smyth RD, Brennan R, Martin GJ. Studies establishing the absorption of the bromelains (proteolytic enzymes) from the gastrointestinal tract. Exp Med Surg 1964;22:46-59.
[15] Glenn J. Managing a traumatic wound in a geriatric patient. Ostomy Wound Manage 2006;52(4):94-8.
[16] Sumi H, Hamada H, Nakanishi K, Hiratani H. Enhancement of the Fibrinolytic Activity in Plasma by Oral Administration of Nattokinase1 Acta Haematol 1990;84:139-143.
[17] Sumi H, Hamada H, Mihara H, Nakanishi K, Hiratani H. Fibrinolytic effects of the Japanese traditional food "natto" (Natokinase). Japan Thromb Haemostas 62: 549, 1989.
[18] Sumi H, Hamada H, Tsushima H, Mihara H, A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto: A typical and popular soybean food in the Japanese diet. Experimentia 43:1110-1111(1987).
[19] Gaby AR. Dehydroepiandrosterone: biological effects and clinical significance. Alt Med Rev 1996;1(2):60-69.
[20] Haning RV Jr., Austin CW, Carlson IH, Kuzma DL, Zweibel WJ. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis. Obstet Gynecol 1985;65(2):199-205.
[21] Thys-Jacobs S, Ceccarelli S, Bierman A, et al. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 1989;4(3):183-189.
[22] Witkowska D, Sedrowicz L, Oledzka R, Bialek A. The effects of zinc and magnesium on calcium uptake into the rat duodenum slices. Biol-Met 1989; 2(1): 36-39.
[23] Puolakka J, Mäkäräinen L, Viinikka L, Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med 1985 Mar;30(3):149-53.
[24] Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991 Oct;30(5):370-2.
[25] Remans PH, Sont JK, Wagenaar LW, Wouters-Wesseling W, Zuijderduin WM, Jongma A, Breedveld FC, Van Laar JM. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur J Clin Nutr 2004 Jun;58(6):839-45.
[26] Magnussen I, Nielsen-Kudsk F. Pharmacokinetics of intravenously administered L-5-hydroxytryptophan in man. Acta Pharmacol Toxicol (Copenh) 1979;44(4):308-314.
[27] van Praag HM, Korf J, Dols LC, Schut T. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia 1972;25(1):14-21.
[28] Zarcone V, Kales A, Scharf M, Tan TL, Simmons JQ, Dement WC. Repeated oral ingestion of 5-hydroxytryptophan. The effect on behavior and sleep processes in two schizophrenic children. Arch Gen Psychiatry 1973;28(6):843-846.
[29] Puttini PS, Caruso I. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res. 1992;20(2):182-189.
[30] Caruso I, Sarzi, Puttini P, Cazzola M, Azzolini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18(3):201-209.
[31] Ribeiro CA. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. Headache 2000;40(6):451-456.
[32] Kotani N, Oyama T, Sakai I, et al. Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea--a double-blind study. Am J Chin Med 1997;25(2):205-212.
[33] Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 11-19-2002;137(10):805-813.
[34] Zhiping H, Dazeng W, Lingyi S, et al. Treating amenorrhea in vital energy-deficient patients with angelica sinensis-astralagus membranaceus menstruation-regulating decoction. J Trad Chin Med 2002;6(3):187-190.
[35] Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 5-22-1999;318(7195):1375-1381.
[36] Sahakian V, Rouse D, Sipes S, Rose N, et al. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol 1991;78(1):33-36.
[37] Thaver D, Saeed MA, Bhutta ZA. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000179.
[38] Mira ML, Azevedo MS, Manso C. The neutralization of hydroxyl radical by silibin, sorbinil and bendazac. Free Radical Res Commun 1987;4(125):129.
[39] Muzes G, Deak G, Lang I. Silymarin (Legalon) kezeles hatasa idult alkoholos majbetegek antioxidans vedorendszerere es a lipid peroxidaciora (kettos vak protokoll). Orvosi Hetilap 1990;131:863-866.
[40] Dehmlow C, Murawski N, de Groot H. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 1996;58(18):1591-1600.
[41] Mascolo N, Autore G, Capasso F, et al. Biological screening of Italian medicinal plants for anti-inflammatory activity. Phytotherapy Res 1987;1(1):28-31.
[42] Bohm K. Studies on the choleretic action of some drugs. Azneim-Forsh 1959;9:376-378.
[43] Hagymasi K, Blazovics A, Feher J, et al. The in vitro effect of dandelions antioxidants on microsomal lipid peroxidation. Phytother Res 2000;14(1):43-44.
[44] Varga E, Hajdu Z, Veres K, Mathe I, Nemeth E, Pluhar Z, Bernath J. Investigation of variation of the production of biological and chemical compounds of Hyssopus officinalis L.. Acta Pharm Hung 1998;68(3):183-188.
[45] Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Di Renzo A, Vinciguerra G, Ricci A, Gizzi G, Ippolito E, Fano F, Dugall M, Acerbi G, Cacchio M. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study. Angiology 2005;56(1):1-8.